Shares in Emeryville, California headquartered Zogenix Inc. recorded a trading volume of 859,814 shares, which was …
Zogenix (NASDAQ: ZGNX) announced solid results in September ... What does all this mean for GW Pharmaceuticals stock? The biotech's market cap currently stands at close to $3.7 billion. If Epidiolex can hit the $1 billion sales mark …
The stock ended at $39.59, rising 1.56% from the last trading session. The stock is trading below its 50-day moving …
WSFA2mon
Results of the second pivotal phase 3 study are expected in Q1 2018. We are initiating coverage on its common stock with Buy rating and initial price target of $30. Zogenix (NASDAQ:ZGNX) is an emerging biopharmaceutical company with …
Call it the yin and yang of the biopharmaceutical industry. Good news for one company is nearly always bad news for another. Zogenix (NASDAQ: ZGNX) announced very good news last week. Its experimental drug ZX008 proved to be …
The stock finished the trading session 1.01% higher at $40.96. The Company's shares have gained 2.76% in the last …
On Friday, shares of pharmaceutical company Zogenix Inc. ZGNX are skyrocketing, and as of 1:05 PM EST, the stock is trading up over 171% to $34.90 per share. ZGNX closed the day on Thursday at $12.88 per share, meaning the small …
Investors in Zogenix, Inc. ZGNX need to pay close attention to the stock based on moves in the options market lately. That is because the Oct 20, 2017 $2 Put had some of the highest implied volatility of all equity options today. What …